Structum caps. 500mg # 60

Structure

1 capsule contains:

Active ingredient: chondroitin sodium sulfate 500 mg

Excipient: talc - 5 mg composition of the capsule shell (body and cap): indigo carmine

titanium dioxide

gelatin.

pharmachologic effect

Structum affects metabolic processes in hyaline and fibrous cartilage, reduces degenerative processes in the cartilage tissue of joints, stimulates the biosynthesis of glycosaminoglycans.

Slows down the resorption of bone tissue and reduces calcium loss, accelerates the processes of bone tissue regeneration.

When using the drug Structum, pain decreases and the mobility of the affected joints improves.

The therapeutic effect lasts a long time after the end of the course of therapy.

Pharmacokinetics

Absorption and distribution

After taking the drug inside, more than 70% of chondroitin sulfate is absorbed from the gastrointestinal tract.

After a single dose in an average therapeutic dose, Cmax in blood plasma is achieved after 3-4 hours, in synovial fluid - after 4-5 hours. The bioavailability of the drug is 13%.

Chondroitin sulfate accumulates in the synovial fluid.

Withdrawal

It is excreted by the kidneys.

Indications

osteoporosis

fractures (to speed up the formation of callus)

arthrosis.

Application during pregnancy and lactation

Not recommended due to lack of sufficient clinical data.

Contraindications

Pregnancy

lactation (breastfeeding).

Side effects

Rarely: allergic reactions, nausea, diarrhea.

Interaction

With the simultaneous use of the drug Structum, it is possible to enhance the action of indirect anticoagulants, antiplatelet agents and fibrinolytics.

How to take, course of administration and dosage

Inside with water.

Adults and adolescents from 15 years old - 1 g / day: 2 capsules (250 mg) or 1 capsule (500 mg) 2 times a day.

The recommended duration of the initial course is 6 months, the period of action of the drug after its withdrawal is 3-5 months, depending on the location and stage of the disease, the duration of repeated courses is set by the doctor.

Special instructions

The drug is prescribed with caution in case of bleeding or a tendency to bleeding.

Name ENG

STRUCTUM

Clinical and pharmacological group

A drug that stimulates the regeneration of cartilage tissue

ATX code

Chondroitin sulfate

Dosage

500mg

Structure

1 capsule contains: Active ingredient: chondroitin sodium sulfate 500 mg

Excipient: talc - 5 mg composition of the capsule shell (body and cap): indigo carmine

titanium dioxide

gelatin.

Indications

osteoarthritis

intervertebral osteochondrosis.

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 3 years

Contraindications

hypersensitivity to drug components

children under 15 years of age (due to the lack of accurate data).

INN / Active ingredient

Chondroitin sulfate

Specifications

Scope of the drug

Musculoskeletal system

Release form

Capsules

Manufacturer country

France

Package quantity, pcs

60

Minimum age from

15 years

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Pierre fabre

The amount of the dosage form in the primary package

20 pcs.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Tissue repair stimulant

Anatomical and therapeutic characteristics

M01AX25 Chondroitin sulfate

Dosage form

Capsules

Expiration date in days

1095

Dosage (volume) of the substance in the preparation

500 mg

The target audience

Children

Package weight, g

one

Category

:

Joints

,

Treatment of diseases of the musculoskeletal system

,

Synovial fluid

,

Bone metabolism

Mode of application

:

Inside with water.

Adults and adolescents from 15 years old - 1 g / day: 2 capsules (250 mg) or 1 capsule (500 mg) 2 times a day.

The recommended duration of the initial course is 6 months, the period of action of the drug after its withdrawal is 3-5 months, depending on the location and stage of the disease, the duration of repeated courses is set by the doctor.